ILIMEX, the Northern Ireland-based provider of biosecurity and air sterilisation solutions, is pleased to announce the conclusion of a funding round which has raised additional equity finance of £600,000 (c. €700,000). This funding will be used to validate the performance of ILIMEX’s Flufence air sterilisation solutions and fund its entry into the agri-food sector with an initial focus on poultry and medicinal mushroom production.

Breakthrough research from the University of Bath and the University of Bristol that demonstrates the real-world efficacy of a passive EEG test in identifying memory decline years before a clinical diagnosis, is being developed as a screening tool by Cumulus Neuroscience.